FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dana Thompson

Research Profile

Procedures

Antineoplastic Combined Chemotherapy Protocols

Chemicals & Drugs

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
John D Hainsworth; William C Penley; Dianna L Shipley; Dana S Thompson; David M Waterhouse; Charles D Webb; F Anthony Greco
Sorafenib and Everolimus in Advanced Clear Cell Renal Carcinoma: A Phase I/II Trial of the SCRI Oncology Research Consortium.
Suzanne F Jones; Adil Mohyuddin; Dana S Thompson; Denise A Yardley; Johanna C Bendell; Jeffrey R Infante; Howard A Burris
A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumors.
David R Spigel; Dana S Thompson; Howard A Burris; Janice F Eakle; F Anthony Greco; Eric T Lubiner; Raven Quinn; Mark S Rubin; Dianna L Shipley; John D Hainsworth
Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dana Thompson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: John D Hainsworth; William C Penley; Dianna L Shipley; Dana S Thompson; David M Waterhouse; Charles D Webb; F Anthony Greco
Sorafenib and Everolimus in Advanced Clear Cell Renal Carcinoma: A Phase I/II Trial of the SCRI Oncology Research Consortium.
Cancer investigation 2013;31(5):323-9.
2012: Suzanne F Jones; Adil Mohyuddin; Dana S Thompson; Denise A Yardley; Johanna C Bendell; Jeffrey R Infante; Howard A Burris
A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumors.
Cancer chemotherapy and pharmacology 2012;70(3):471-5.
2012: David R Spigel; Dana S Thompson; Howard A Burris; Janice F Eakle; F Anthony Greco; Eric T Lubiner; Raven Quinn; Mark S Rubin; Dianna L Shipley; John D Hainsworth
Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2012;77(2):359-64.
2012: Suzanne F Jones; William McCulloch; Nancy W Peacock; David R Spigel; Dana S Thompson; F Anthony Greco; Jeffrey R Infante; Howard A Burris
Phase 1 results from a study of romidepsin in combination with gemcitabine in patients with advanced solid tumors.
Cancer investigation 2012;30(6):481-6.
2011: Suzanne F Jones; Johanna C Bendell; Jeffrey R Infante; David R Spigel; Dana S Thompson; Denise A Yardley; F Anthony Greco; Patrick B Murphy; Howard A Burris
A phase I study of panobinostat in combination with gemcitabine in the treatment of solid tumors.
Clinical advances in hematology & oncology : H&O 2011;9(3):225-30.
2010: Denise A Yardley; Michael McCleod; Fred Schreiber; Patrick Murphy; Jeffrey Patton; Dana S Thompson; Mythili Shastry; Mark Rubin; Marianne Melnik; Howard A Burris; John D Hainsworth
A phase II trial of vinflunine as monotherapy or in combination with trastuzumab as first-line treatment of metastatic breast cancer.
Cancer investigation 2010;28(9):925-31.
2010: John D Hainsworth; Jeffrey R Infante; David R Spigel; James D Peyton; Dana S Thompson; Cassie M Lane; Bobby L Clark; Mark S Rubin; David F Trent; Howard A Burris
Bevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.
Cancer 2010;116(17):4122-9.
2010: David R Spigel; F Anthony Greco; Dana S Thompson; Charles Webb; James Rubinsak; Roger C Inhorn; James Reeves; Elizabeth R Vazquez; Cassie M Lane; Howard A Burris; John D Hainsworth
Phase II study of cetuximab, docetaxel, and gemcitabine in patients with previously untreated advanced non-small-cell lung cancer.
Clinical lung cancer 2010;11(3):198-203.
2010: Howard A Burris; Jeffrey R Infante; Roxanne C Jewell; David R Spigel; F Anthony Greco; Dana S Thompson; Suzanne F Jones
A phase I study of weekly topotecan in combination with pemetrexed in patients with advanced malignancies.
The oncologist 2010;15(9):954-60.
2009: John D Hainsworth; David R Spigel; Dana S Thompson; Patrick B Murphy; Cassie M Lane; David M Waterhouse; Yuval Naot; F Anthony Greco
Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site.
The oncologist 2009;14(12):1189-97.
2007: F Anthony Greco; David R Spigel; Michel E Kuzur; Dianna L Shipley; James R Gray; Dana S Thompson; Howard A Burris; Denise A Yardley; Asim Pati; Charles D Webb; Jitendra G Gandhi; John D Hainsworth
Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Network.
Clinical lung cancer 2007;8(8):483-7.
2007: John D Hainsworth; David R Spigel; Cindy Farley; Dana S Thompson; Dianna L Shipley; F Anthony Greco
Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(13):1747-52.
2005: F Anthony Greco; Dana S Thompson; Lisa H Morrissey; Joan B Erland; Howard A Burris; David R Spigel; Geetha Joseph; Stephen Corso; Ellen Spremulli; John D Hainsworth
Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: a Minnie Pearl Cancer Research Network randomized, prospective phase II trial.
The oncologist 2005;10(9):728-33.
2005: Suzanne F Jones; John Kuhn; F Anthony Greco; Eric L Raefsky; John D Hainsworth; Natalie R Dickson; Dana S Thompson; Noel T Willcutt; Melissa B White; Howard A Burris
A phase I/II study of exisulind in combination with docetaxel/carboplatin in patients with metastatic non-small-cell lung cancer.
Clinical lung cancer 2005;6(6):361-6.
2003: John D Hainsworth; Joan B Erland; John H Barton; Dana S Thompson; M Patrick Stagg; James E Bradof; Thomas W Twele; E Anthony Greco
Combination treatment with weekly docetaxel and gemcitabine for advanced non-small-cell lung cancer in elderly patients and patients with poor performance status: results of a Minnie Pearl Cancer Research Network phase II trial.
Clinical lung cancer 2003;5(1):33-8.
2003: Suzanne F Jones; Victor G Gian; F Anthony Greco; Fernando T Miranda; Dianna L Shipley; Dana S Thompson; John D Hainsworth; Mitchell A Toomey; Noel T Willcutt; Howard A Burris
Phase I. Trial of irinotecan and temozolomide in patients with solid tumors.
Oncology (Williston Park, N.Y.) 2003;17(5 Suppl 5):41-5.
2002: F Anthony Greco; James R Gray; Dana S Thompson; Howard A Burris; Joan B Erland; John H Barton; Sharlene Litchy; Gerry Ann Houston; James A Butts; Charles Webb; Charles Scott; John D Hainsworth
Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.
Cancer 2002;95(6):1279-85.